Filing
Spy
Filing
Spy
Home
About
IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2013 Q2
5 of 7 quarters
Total Value
$96.63M
Total Shares
26.77M
Net Share Change
+725.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$96.63M
26.77M
2.4%
ADD
+725.0K
(+2.8%)
Baupost Group LLC
$96.63M
26.77M shares
ADD
+725.0K
(+2.8%)
IDIX — Idenix Pharmaceuticals Inc - FilingSpy